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Abstract
We relate innovation to sales growth for incumbent ﬁrms in high-tech sectors. A
ﬁrm, on average, experiences only modest growth and may grow for a number of reasons
that may or may not be related to ‘innovativeness’. However, given that the returns
to innovation are highly skewed and that growth rates distributions are heavy-tailed, it
may be misleading to use regression techniques that focus on the ‘average eﬀect for the
average ﬁrm’. Using a quantile regression approach, we observe that innovation is of
crucial importance for a handful of ‘superstar’ fast-growth ﬁrms. We also discuss policy
implications of our results.
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11 Introduction
1.1 In Search of the Determinants of Firm Growth
Early contributions on ﬁrm growth focused on the empirical validation of Gibrat’s Law, also
known as the Law of Proportionate Eﬀect. Taken in its simplest form, this ‘law’ predicts
that expected growth rates are independent of ﬁrm size. Regressions have found, in general,
that growth patterns in modern economies are characterized by a weak negative dependence
of growth rates on size (i.e. a slight reversion to the mean), leading us to reject Gibrat’s Law
(among a large number of studies see for example Mansﬁeld (1962), Hall (1987), Evans (1987),
Hart and Oulton (1996), Bottazzi et al. (2005), Bottazzi et al. (2006); see also Sutton (1997)
for a review). Mean-reversion is typically observed in samples of small ﬁrms, but is much
weaker or even nonexistent for larger ﬁrms (Mowery (1983), Hart and Oulton (1996), Lotti et
al. (2003)). Although strictly speaking we are led to reject Gibrat’s Law, it does appear to
be useful as a rough ﬁrst approximation. Size does not appear to be a major determinant of
the rate of growth – indeed, the explanatory power of Gibrat-type regressions is often found
to be rather low, and the coeﬃcient estimates, though signiﬁcant, are often quite small.
Attention has also been placed on the inﬂuence of other factors on ﬁrm growth, using a
variety of diﬀerent databases. One classic research topic has been to investigate the inﬂuence of
age on ﬁrm growth. Indeed, it has even been suggested that the correct causality runs from age
to size to growth, such that size has no eﬀect on the expected growth rates if age is taken into
account (Fizaine, 1968; Evans, 1987). In any case, age is observed to have a negative inﬂuence
on ﬁrm growth. Legal status seems to have an inﬂuence, with public ﬁrms and ﬁrms with
limited liability having signiﬁcantly higher growth rates in comparison with other companies
(Harhoﬀ et al., 1998). Proprietary structure also appears to aﬀect growth, when this latter is
taken at the plant-level. Evidence suggests that the expected growth rate of a plant declines
with size for plants owned by single-plant ﬁrms but increases with size for plants owned by
multiplant ﬁrms (Dunne et al., 1989). Looking at data on industry leaders, Geroski and Toker
(1996) identify other variables that are observed to inﬂuence growth. Advertising expenditure,
the demand growth of an industry, and also the industry concentration are observed to have
a positive inﬂuence on ﬁrm growth rates.
However, even though such explorations into the determinants of ﬁrm growth rates may
obtain coeﬃcient estimates that are statistically signiﬁcant, the explanatory power is remark-
ably weak (Geroski, 2000). “In short, the empirical evidence suggests that although there are
systematic factors at the ﬁrm and industry levels that aﬀect the process of ﬁrm growth, growth
is mainly aﬀected by purely stochastic shocks...” (Marsili, 2001:18). “The most elementary
‘fact’ about corporate growth thrown up by econometric work on both large and small ﬁrms
2is that ﬁrm size follows a random walk” (Geroski, 2000:169). It seems that there is little
more that we can say about ﬁrm growth rates apart from that they are largely unpredictable,
stochastic, and idiosyncratic (see the survey in Coad (2007)).
1.2 Innovation and Sales Growth – What do we know?
The relationship between innovation and sales growth can be described as something of a
paradox – on the one hand, a broad range of theoretical and descriptive accounts of ﬁrm growth
stress the important role innovation plays for ﬁrms wishing to expand their market share.
For example, Carden (2005: 25) presents the main results of the McKinsey Global Survey
of Business Executives, and writes that “[e]xecutives overwhelmingly say that innovation is
what their companies need most for growth.” Another survey focusing on SMEs (Small and
Medium Enterprises) reports that investment in product innovation is the single most popular
strategy for expansion, a ﬁnding which holds across various industries (Hay and Kamshad,
1994). Economic theorizing also recognizes the centrality of innovation in growth of ﬁrm sales
(see for example the discussion in Geroski (2000, 2005) or the theoretical model in Aghion
and Howitt (1992)). On the other hand, empirical studies have had diﬃculty in identifying
any strong link between innovation and sales growth, and the results have often been modest
and disappointing. Indeed, some studies fail to ﬁnd any inﬂuence of innovation on sales
growth at all. Commenting on the current state of our understanding of ﬁrm-level processes
of innovation, Ceﬁs and Orsenigo (2001) write: “Linking more explicitly the evidence on the
patterns of innovation with what is known about ﬁrms growth and other aspects of corporate
performance – both at the empirical and at the theoretical level – is a hard but urgent challenge
for future research” (Ceﬁs and Orsenigo, 2001: 1157).
A major diﬃculty in observing the eﬀect of innovation on growth is that it may take a
ﬁrm a long time to convert increases in economically valuable knowledge (i.e. innovation) into
economic performance. Even after an important discovery has been made, a ﬁrm will typically
have to invest heavily in product development. In addition, converting a product idea into a
set of successful manufacturing procedures and routines may also prove costly and diﬃcult.
Furthermore, even after an important discovery has been patented, a ﬁrm in an uncertain
market environment may prefer to treat the patent as a ‘real option’ and delay associated
investment and development costs (Bloom and Van Reenen, 2002). There may therefore be
considerable lags between the time of discovery of a valuable innovation and its conversion
into commercial success. Another feature of the innovation process is that there is uncertainty
at every stage, and that the overall outcome requires success at each step of the process. In a
pioneering empirical study, Mansﬁeld et al. (1977) identify three diﬀerent stages of innovation
that correspond to three diﬀerent conditional probabilities of success: the probability that
3a project’s technical goals will be met (x); the probability that, given technical success, the
resulting product or process will be commercialized (y); and ﬁnally the probability that, given
commercialization, the project yields a satisfactory return on investment (z). The overall
success of the innovative activities will be the product of these three conditional probabilities
(x × y × z). If a ﬁrm fails at any of these stages, it will have incurred costs without reaping
beneﬁts. We therefore expect that ﬁrms diﬀer greatly both in terms of the returns to R&D
(measured here in terms of post-innovation sales growth) and also in terms of the time required
to convert an innovation into commercial success. However, it is anticipated that innovations
will indeed pay oﬀ on average and in the long term, otherwise commercial businesses would
obviously have no incentive to perform R&D in the ﬁrst place.
How do ﬁrms translate innovative activity into competitive advantage?1 Our gleaning
of this literature of the inﬂuence of innovative activity on sales growth yields a sparse and
rather motley harvest. (This may be due to diﬃculties in linking ﬁrm-level innovation data
to other ﬁrm characteristics.) Mansﬁeld (1962) considers the steel and petroleum sectors over
a 40-year period, and ﬁnds that successful innovators grew quicker, especially if they were
initially small. Moreover, he asserts that the higher growth rate cannot be attributed to their
pre-innovation behavior. Another early study by Scherer (1965) looks at 365 of the largest
US corporations and observes that inventions (measured by patents) have a positive eﬀect on
company proﬁts via sales growth. Of particular interest to this study is his observation that
innovations typically do not increase proﬁt margins but instead increase corporate proﬁts via
increased sales at constant proﬁt margins. This suggests that sales growth is a particularly
meaningful indicator of post-innovation performance. Mowery (1983) focuses on the dynamics
of US manufacturing over the period 1921-1946 and observes that R&D employment only
has a signiﬁcantly positive impact on ﬁrm growth (in terms of assets) for the period 1933-
46. Furthermore, using two diﬀerent samples, he observes that R&D has a similar eﬀect on
growth for both large and small ﬁrms. Geroski and Machin (1992) look at 539 large quoted
UK ﬁrms over the period 1972-83, of which 98 produced an innovation during the period
considered. They observe that innovating ﬁrms (i.e. ﬁrms that produced at least one ‘major’
innovation) are both more proﬁtable and grow faster than non-innovators. The inﬂuence
of speciﬁc innovations on sales growth are nonetheless short-lived (p. 81) - “the full eﬀects
of innovation on corporate growth are realized very soon after an innovation is introduced,
generating a short, sharp one-oﬀ increase in sales turnover.” In addition, and contrary to
Scherer’s ﬁndings, they observe that innovativeness has a more noticeable inﬂuence on proﬁt
1This is not the place to consider how innovative activity aﬀects other aspects of ﬁrm performance apart from
sales growth. For a survey of the literature on innovation and market value appreciation, see the introduction
in Hall and Oriani (2006), and for a survey on the relationship between innovation and employment growth
(i.e. the ‘technological unemployment’ literature) see Niefert (2005). See also Harrison et al. (2005) and Hall
et al. (2006) for some investigations into the employment eﬀects of product and process innovations.
4Figure 1: The Knowledge ‘Production Function’: A Simpliﬁed Path Analysis Diagram (based
on Griliches 1990:1671)
margins than on sales growth. Geroski and Toker (1996) look at 209 leading UK ﬁrms and
observe that innovation has a signiﬁcant positive eﬀect on sales growth, when included in an
OLS regression model amongst many other explanatory variables. Roper (1997) uses survey
data on 2721 small businesses in the U.K., Ireland and Germany to show that innovative
products introduced by ﬁrms made a positive contribution to sales growth. Freel (2000)
considers 228 small UK manufacturing businesses and, interestingly enough, observes that
although it is not necessarily true that ‘innovators are more likely to grow’, nevertheless
‘innovators are likely to grow more’ (i.e. they are more likely to experience particularly rapid
growth). Finally, Bottazzi et al. (2001) study the dynamics of the worldwide pharmaceutical
sector and do not ﬁnd any signiﬁcant contribution of a ﬁrm’s ‘technological ID’ or innovative
position2 to sales growth. 3
A critical examination of these studies reveals that the proxies that they use to quantify
‘innovativeness’ are rather noisy. Figure 1, taken from Griliches (1990), explains that the vari-
able of interest (i.e. ∆K – additions to economically valuable knowledge) is measured with
2They measure a ﬁrm’s innovativeness by either the discovery of NCE’s (new chemical entities) or by the
proportion of patented products in a ﬁrm’s product portfolio
3It is also worth mentioning here research by H¨ olzl and Friesenbichler (2007), which came to our attention
but recently. These authors also apply quantile regression techniques to the relationship between innovation
and ﬁrm growth, and (among other results) observe that new products are of especially great importance for
the growth of ‘gazelles’, or fast-growth small ﬁrms.
5noise if one takes patent statistics P as a measure of innovative output. In order to remove
this noise, we collect information on both innovative input (R&D) and output (patents), and
extract the common variance whilst discarding the idiosyncratic variance of each individual
proxy that includes noise, measurement error, and speciﬁc variation. In this way, we believe
we have obtained useful data on a ﬁrm’s innovativeness by considering both R&D expenditure
and patent statistics simultaneously in a synthetic variable.4 Another criticism is that previous
studies have lumped together ﬁrms from all manufacturing sectors – even though innovation
regimes vary dramatically across industries. In this study, we focus on speciﬁc 2-digit and
3-digit sectors that have been hand-picked according to their intensive patenting and R&D
activity. However, even within these sectors, there is signiﬁcant heterogeneity between ﬁrms,
and using standard regression techniques to make inferences about the average ﬁrm may mask
important phenomena. Using quantile regression techniques, we investigate the relationship
between innovativeness and growth at a range of points of the conditional growth rate distri-
bution. We observe that, whilst for the ‘average ﬁrm’ innovativeness may not be so important
for sales growth, innovativeness is of crucial importance for the ‘superstar’ high-growth ﬁrms.
The aim of this paper is therefore to apply novel statistical techniques in an attempt to
reconcile quantitative empirical ﬁndings, which have often found only a rather modest role of
innovation on sales growth, with theoretical intuitions and qualitative empirical work which
have emphasized the crucial role of innovation in ﬁrm growth. To this end, we apply quantile
regression techniques, which appear well-suited to the study of innovation because of the
fundamental heterogeneity in the returns to innovation. Our research methodology is thus in
line with an earlier exhortation for research into ﬁrm growth: “The subject of organizational
growth has progressed beyond abysmal darkness. It is ready for – and badly needs – solid,
systematic empirical research directed toward explicit hypotheses and utilizing sophisticated
statistical methods” (Starbuck, 1971: 126).
In Section 2 we discuss the methodology, focusing in particular on the shortcomings of
using either patent counts or R&D ﬁgures individually as proxies for innovativeness. We de-
scribe how we use Principal Component Analysis to extract a synthetic ‘innovativeness’ index
from patent and R&D data. Section 3 describes how we matched the Compustat database
to the NBER patent database, and we present the synthetic ‘innovativeness’ index. Section 4
contains the quantile regression analysis, beginning with a brief introduction to quantile re-
gression (Section 4.1) before we present the results (Section 4.2). We explore the robustness
of our results in Section 5. Indeed, our results appear to be robust to sectoral disaggrega-
4Griliches (1990) considers that patent counts can be used as a measure of innovative output, although this
is not entirely uncontroversial. Patents have a highly skew value distribution and many patents are practically
worthless. As a result, patent numbers have limitations as a measure of innovative output – some authors
would even prefer to consider raw patent counts to be indicators of innovative input. We take an intermediary
stance and consider patents as being partway between an input and an output.
6tion, temporal disaggregation, robust to alternative indicators for innovative activity, and also
robust to the use of an alternative dataset (i.e. the Hall-Jaﬀe-Trajtenberg (2005) dataset).
Section 6 contains implications for policy and some concluding thoughts.
2 Methodology - How can we measure innovativeness?
Activities related to innovation within a company can include research and development;
acquisition of machinery, equipment and other external technology; industrial design; and
training and marketing linked to technological advances. These are not necessarily identiﬁed
as such in company accounts, so quantiﬁcation of related costs is one of the main diﬃculties
encountered during the innovation studies. Each of the above mentioned activities has some
eﬀect on the growth of the ﬁrm, but the singular and cumulative eﬀect of each of these activities
is hard to quantify. Data on innovation per se has thus been hard to ﬁnd (Van Reenen, 1997).
Also, some sectors innovative extensively, some don’t innovative in a tractable manner, and
the same is the case with organizational innovations, which are hard to quantify in terms
of impact on the overall growth of the ﬁrms. However, we believe that no ﬁrm can survive
without at least some degree of innovation.
We use two indicators for innovation in a ﬁrm: ﬁrst, the patents applied for by a ﬁrm
and second, the amount of R&D undertaken. Cohen et al. (2000) suggest that no industry
relies exclusively on patents, yet the authors go on to suggest that the patents may add
suﬃcient value at the margin when used with other appropriation mechanisms. Although
patent data has drawbacks, patent statistics provide unique information for the analysis of
the process of technical change (Griliches, 1990). We can use patent data to access the patterns
of innovation activity across ﬁelds (or sectors) and nations. The number of patents can be
used as an indicator of inventive as well as innovative activity, but it has its limitations. One
of the major disadvantage of patents as an indicator is that not all inventions and innovations
are patented (or indeed ‘patentable’). Some companies – including a number of smaller ﬁrms –
tend to ﬁnd the process of patenting expensive or too slow and implement alternative measures
such as secrecy or copyright to protect their innovations (Archibugi, 1992; Arundel and Kabla,
1998). Another bias in the study using patenting can arise from the fact that not all patented
inventions become innovations. The actual economic value of patents is highly skewed, and
most of the value is concentrated in a very small percentage of the total (OECD, 1994).
Furthermore, another caveat of using patent data is that we may underestimate innovation
occuring in large ﬁrms, because these typically have a lower propensity to patent (Dosi, 1988).
The reason we use patent data in our study is that, despite the problems mentioned above,
patents should reﬂect the continuous developments within technology (Engelsman and van
Raan, 1990). We complement the patent data with R&D data. R&D can be considered as an
7input into the production of inventions, and patents as outputs of the inventive process. R&D
data may lead us to systematically underestimate the amount of innovation in smaller ﬁrms,
however, because these often innovate on a more informal basis outside of the R&D lab (Dosi,
1988). For some of the analysis we consider the R&D stock and also the patent stock, since
the past investments in R&D as well as the past applications of patents have an impact not
only on the future values of R&D and patents, but also on ﬁrm growth. Hall (2004) suggests
that the past history of R&D spending is a good indicator of the ﬁrms technological position.
Taken individually, each of these indicators for ﬁrm-level innovation has its drawbacks.
Each indicator on its own provides useful information on a ﬁrm’s innovative activity, but also
idiosyncratic variance that may be unrelated to a ﬁrm’s innovative activity. One particular
feature pointed out by Griliches (1990) is that, although patent data and R&D data are
often chosen to individually represent the same phenomenon, there exists a major statistical
discrepancy in that there is typically a great randomness in patent series, whereas R&D
values are much more smoothed. Principal Component Analysis (PCA) is appropriate here as
it allows us here to summarize the information provided by several indicators of innovativeness
into a composite index, by extracting the common variance from correlated variables whilst
separating it from the speciﬁc and error variance associated with each individual variable (Hair
et al., 1998). We are not the only ones to apply PCA to studies into ﬁrm-level innovation
however – this technique has also been used by Lanjouw and Schankerman (2004) to develop
a composite index of ‘patent quality’ using multiple characteristics of patents (such as the
number of citations, patent family size and patent claims).
We only consider certain speciﬁc sectors, and not the whole of manufacturing. This way
we are not aﬀected by aggregation eﬀects; we are grouping together ﬁrms that can plausibly
be compared to each other. We are particularly interested in looking at the growth of ﬁrms in
highly innovative industries. To this end, we base our analysis on ﬁrms in ‘complex’ technology
industries (although we also examine pharmaceutical ﬁrms). We base our classiﬁcation of such
ﬁrms on the typology put forward by Hall (2004) and Cohen et al. (2000). The authors deﬁne
‘complex product’5 industries as those industries where each product relies on many patents
held by a number of other ﬁrms and the ‘discrete product’ industries as those industries where
each product relies on only a few patents and where the importance of patents for appro-
priability has traditionally been higher.6 We chose four sectors that can be classiﬁed under
the ‘complex products’ class. The two digit SIC codes that match the ‘complex technology’
sectors are SIC 35 (industrial and commercial machinery and computer equipment), SIC 36
(electronic and other electrical equipment and components, except computer equipment), SIC
5During our discussion, we will use the terms ‘products’ and ‘technology’ interchangeably to indicate gen-
erally the same idea.
6It would have been interesting to include ‘discrete technology’ sectors in our study, but unfortunately we
did not have a comparable number of observations for these sectors. This remains a challenge for future work.
837 (transportation equipment) and SIC 38 (measuring, analyzing and controlling instruments;
photographic, medical and optical goods; watches and clocks). Our analysis also includes
pharmaceutical ﬁrms (SIC 283), because of their intensive patenting activity. To summarize,
then, our dataset can be said to include high-tech ‘complex technology’ industries (SIC’s 35,
36 and 38), a ‘complex technology’ sector that is, technologically speaking, more mature (SIC
37 – Transportation) and a high-tech sector that nonetheless cannot be classiﬁed as a ‘com-
plex technology’ industry (SIC 283 – Drugs). By choosing these sectors that are characterised
by high patenting and high R&D expenditure, we hope that we will be able to get the best
possible quantitative observations for ﬁrm-level innovation.
3 Database description
3.1 Database
We create an original database by matching the NBER patent database with the Compustat
ﬁle database, and this section is devoted to describing the creation of the sample which we
will use in our analysis.
The patent data has been obtained from the NBER database (Hall et al., 2001b), and we
have used the updates available on Bronwyn Hall’s website7 to obtain data until 2002. The
NBER database comprises detailed information on almost 3 416 957 U.S. utility patents in the
USPTO’s TAF database granted during the period 1963 to December 2002 and all citations
made to these patents between 1975 and 2002. The initial sample of ﬁrms was obtained from
the Compustat8 database for the aforementioned sectors comprising ‘complex product’ sectors.
These ﬁrms were then matched with the ﬁrm data ﬁles from the NBER patent database and
we found all the ﬁrms9 that have patents. The ﬁnal sample thus contains both patenters and
7See http://elsa.berkeley.edu/∼bhhall/bhdata.html
8Compustat has the largest set of fundamental and market data representing 90% of the world’s market
capitalization. Use of this database could indicate that we have oversampled the Fortune 500 ﬁrms. Being
included in the Compustat database means that the number of shareholders in the ﬁrm was large enough for the
ﬁrm to command suﬃcient investor interest to be followed by Standard and Poor’s Compustat, which basically
means that the ﬁrm is required to ﬁle 10-Ks to the Securities and Exchange Commission on a regular basis.
It does not necessarily mean that the ﬁrm has gone through an IPO. Most of them are listed on NASDAQ or
the NYSE.
9The patent ownership information (obtained from the above mentioned sources) reﬂects ownership at the
time of patent grant and does not include subsequent changes in ownership. Also attempts have been made
to combine data based on subsidiary relationships. However, where possible, spelling variations and variations
based on name changes have been merged into a single name. While every eﬀort is made to accurately identify
all organizational entities and report data by a single organizational name, achievement of a totally clean record
is not expected, particularly in view of the many variations which may occur in corporate identiﬁcations. Also,
the NBER database does not cumulatively assign the patents obtained by the subsudiaries to the parents, and
we have taken this limitation into account and have subsequently tried to cumulate the patents obtained by
the subsidiaries towards the patent count of the parent. Thus we have attempted to create an original database
that gives complete ﬁrm-level patent information.
9Table 1: Summary statistics before and after data-cleaning (1963-1998; SIC’s 35-38 only).
Sales and R&D deﬂated to millions of 1980 dollars.
sample before cleaning sample used
n=4012 ﬁrms n=2113 ﬁrms
mean median 25% 75% std. dev. mean median 25% 75% std. dev.
Total Sales 674.81 32.66 7.87 146.75 3923.06 817.42 35.08 8.46 173.74 4468.37
Patent applications 6.33 0 0 1 44.66 8.34 0 0 1 53.03
R&D expenditure 31.05 1.19 0.25 5.45 188.72 35.54 1.3 0.27 6.34 203.64
non-patenters.
The NBER database has patent data for over 60 years and the Compustat database has
ﬁrms’ ﬁnancial data for over 50 years, giving us a rather rich information set. As Van Reenen
(1997) mentions, the development of longitudinal databases of technologies and ﬁrms is a
major task for those seriously concerned with the dynamic eﬀect of innovation on ﬁrm growth.
Hence, having developed this longitudinal dataset, we feel that we will be able to thoroughly
investigate whether innovation drives sales growth at the ﬁrm-level.
Table 1 shows some descriptive statistics of the sample before and after cleaning. Initially
using the Compustat database, we obtain a total of 4395 ﬁrms which belong to the SICs 35-38
and this sample consists of both innovating and non-innovating ﬁrms. These ﬁrms were then
matched to the NBER database.
After this initial match, we further matched the year-wise ﬁrm data to the year-wise patents
applied by the respective ﬁrms (in the case of innovating ﬁrms) and ﬁnally, we excluded ﬁrms
that had less than 7 consecutive years of good data. We do not remove ﬁrms that have
growth rates above a certain threshold level for two reasons. First, we are interested in high
growth ﬁrms and do not want to exclude them. Since we have no way of identifying ﬁrms that
underwent mergers or acquisitions, we do not attempt to remove these ﬁrms. Second, we use
a regression estimator that is robust to outliers (the quantile regression estimates are robust
to outliers on the dependent variable that tend to ± ∞). As a result, we have an unbalanced
panel of 2113 ﬁrms belonging to 4 diﬀerent sectors. Since we intend to take into account
sectoral eﬀects of innovation, we will proceed on a sector by sector basis, to have (ideally) 4
comparable results for 4 diﬀerent sectors.
We also show results for four 3-digit sectors as further evidence that our results are not
driven by mere statistical aggregation. These 3-digit sectors were chosen because they have
featured in numerous industry case studies into the dynamics of high-tech sectors. We also
felt that the peculiarities of the dynamics of these industries may not be as visible when they
are ‘lumped’ together with their 2-digit ‘classmates’ that are sometimes quite dissimilar.10
The 3-digit sectors that we study are SIC 357 (Computers and oﬃce equipment), SIC 367





























Figure 2: Number of patents per year. SIC
35: Machinery & Computer Equipment, SIC
36: Electric/Electronic Equipment, SIC 37:


























Figure 3: Number of patents per year. SIC
357: Computers and oﬃce equipment, SIC
367: Electronics, SIC 384: Medical Instru-
ments, and SIC 283: Drugs.
Table 2: The Distribution of Firms by Total Patents (1963-1997; SIC’s 35-38 only)
0 or more 1 or more 10 or more 25 or more 100 or more 250 or more 1000 or more
Firms 2113 1060 621 405 175 108 46
(Electronics); SIC 384 (Medical Instruments) and SIC 283 (Drugs).11
Figures 2 and 3 show the number of patents per year in our ﬁnal database. Since we have
patchy data for the period prior to 1963, we begin our analysis in 1963 only. For some of
the sectors there appears to be a strong structural break at the beginning of the 1980s which
may well be due to changes in patent regulations (see Hall (2004) for a discussion). Table 2
presents the ﬁrm-wise distribution of patents, which is noticeably right-skewed. We ﬁnd that
47% of the ﬁrms in our sample have no patents. Thus the intersection of the two datasets
gave us 1060 patenting ﬁrms who had taken out at least one patent between 1963 and 1999,
and 1053 ﬁrms that had no patents during this period. The total number of patents taken
out by this group over the entire period was 332 888, where the entire period for the NBER
database represented years 1963 to 2002, and we have used 233 703 of these patents in our
analysis i.e. representing about 70% of the total patents ever taken out at the US Patent
Oﬃce by the ﬁrms in our sample. Though the NBER database provides the data on patents
applied for from 1963 till 2002, it contains information only on the granted patents and hence
we might see some bias towards the ﬁrms that have applied in the end period covered by
the database due the lags faced between application and the grant of the patents. Hence to
avoid this truncation bias (on the right) we use the patent data till 1997 only so as to account
11The reader may have noticed that SIC 283 (Drugs) does not lie in the SIC 35-38 range for which the
database creation procedure is described above. It was necessary to create a new dataset, using an analogous
procedure to that described above for SIC’s 35-38, to collect data for this 3-digit sector.
11Table 3: Contemporaneous correlations between Patents and R&D expenditure
SIC 35 SIC 36 SIC 37 SIC 38 SIC 357 SIC 367 SIC 384 SIC 283
CORRELATIONS
ρ 0.5379 0.3482 0.5120 0.6731 0.5401 0.6981 0.6970 0.4986
p-value 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000
RANK CORRELATIONS
ρ 0.4212 0.4496 0.4232 0.4577 0.4989 0.5545 0.4548 0.5043
p-value 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000
Obs. 9336 9517 2892 8292 3883 3261 3253 3938
for the gap between application and grant of the patent.12 Because of the lag structure in
the regressions, we have data on ﬁrm growth till 1998. We therefore restrict our attention to
observations between 1963 and 1998, which leaves us with 2113 ﬁrms.
3.2 Summary statistics and the ‘innovativeness’ index
Table 3 shows that patent numbers are well correlated with (deﬂated) R&D expenditure, albeit
without controlling for ﬁrm size. To take this into account, Table 4 reports the correlations
between ﬁrm-level patent intensity and R&D intensity. We prefer the rank correlations here,
because they are more robust to outliers. For each of the sectors we observe positive and
highly signiﬁcant rank correlations, which nonetheless take values of 0.4 or lower. These
results would thus appear to be consistent with the idea that, even within industries, patent
and R&D statistics do contain large amounts of idiosyncratic variance and that either of these
variables taken individually would be a rather noisy proxy for ‘innovativeness’.13 Indeed, as
discussed in Section 2, these two variables are quite diﬀerent not only in terms of statistical
properties (patent statistics are much more skewed and less persistent than R&D statistics)
but also in terms of economic signiﬁcance. However, they both yield valuable information on
ﬁrm-level innovativeness.
Our synthetic ‘innovativeness’ index is created by extracting the common variance from
a series of related variables: both patent intensity and R&D intensity at time t, and also
the actualized stocks of patents and R&D.14 These stock variables are calculated using the
12This gap between patent application and grant has been referred to by many authors, among others Bloom
and Van Reenen (2002) who mention a lag of two years between application and grant, and Hall et al. (2001a)
who state that 95% of the patents that are eventually granted are granted within 3 years of application.
However, it has been suggested that this gap has lengthened in recent years (an observation which appears to
be corroborated in Figures 2 and 3), and as a consequence we allow for a longer gap in our analysis.
13Further evidence of the discrepancies between patent statistics and R&D statistics is presented in the
regression results in Tables 5 and 6 of Coad and Rao (2006a).
14Note that, in the regression analysis, R&D and patent intensities are calculated by scaling down values of
R&D and patents (at time t) by sales (at time t−1) in order to avoid statistical issues related to the ‘regression
fallacy.’
12Table 4: Contemporaneous correlations between ‘patent intensity’ (patents/sales) and ‘R&D
intensity’ (R&D/sales)
SIC 35 SIC 36 SIC 37 SIC 38 SIC 357 SIC 367 SIC 384 SIC 283
CORRELATIONS
ρ 0.0269 0.7549 0.0290 0.1187 0.0269 0.6090 0.0719 0.3806
p-value 0.0125 0.0000 0.1310 0.0000 0.1080 0.0000 0.0001 0.0000
RANK CORRELATIONS
ρ 0.1158 0.2072 0.2088 0.1840 0.0756 0.3807 0.1975 0.3398
p-value 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000
Obs. 8642 8814 2707 7689 3566 3031 2993 3579
Table 5: Extracting the ‘innovativeness’ index used for the quantile regressions - Principal
Component Analysis results (ﬁrst component only, unrotated)
SIC 35 SIC 36 SIC 37 SIC 38 SIC 357 SIC 367 SIC 384 SIC 283
R&D / Sales 0.4303 0.4365 0.4549 0.4130 0.4347 0.4249 0.4213 0.4264
Patents / Sales 0.3975 0.2296 0.3420 0.4070 0.4001 0.2964 0.3952 0.3716
R&D stock / Sales (δ=15%) 0.3976 0.4510 0.4550 0.4075 0.3953 0.4344 0.4201 0.4266
Pat. stock / Sales (δ=15%) 0.4134 0.4255 0.3602 0.4069 0.4122 0.4202 0.3957 0.3948
R&D stock / Sales (δ=30%) 0.3949 0.4495 0.4567 0.4082 0.3924 0.4346 0.4202 0.4270
Pat. stock / Sales (δ=30%) 0.4146 0.4126 0.3616 0.4069 0.4134 0.4213 0.3957 0.4000
Propn Variance explained 0.6919 0.6897 0.5149 0.5527 0.7024 0.7815 0.5166 0.6794
No. Obs. 7934 8100 2499 7080 3254 2788 2736 3238
conventional amortizement rate of 15%, and also at the rate of 30% since we suspect that the
15% rate may be too low (Hall and Oriani, 2006). Information on the factor loadings is shown
in Table 5. We consider the summary ‘innovativeness’ variable to be a satisfactory indicator of
ﬁrm-level innovativeness because it loads well with each of the variables and explains between
51% to 78% of the total variance. An advantage of this composite index is that a lot of
information on a ﬁrm’s innovative activity can be summarized into one variable (this will
be especially useful in the following graphs). A disadvantage is that the units have no ready
interpretation (unlike ‘one patent’ or ‘$1 million of R&D expenditure’). In this study, however,
we are less concerned with the quantitative point estimates than with the qualitative variation
in the importance of innovation over the conditional growth rate distribution (i.e. the ‘shape’
of the graphs).
Figure 4 presents some scatterplots of innovativeness on sales growth, for the four 2-digit
sectors. (Bear in mind that the innovativeness indicator has been normalized to having a
mean 0.0000, and that it is truncated at the left, which reﬂects the fact that patenting and
R&D activity are limited to taking non-negative values only.) The innovativeness variable is
calculated at time t − 1 but, by construction, it contains information on innovative activity
over the period t − 3 : t − 1. The relationships presented in the plots are admittedly very
noisy, with the expected positive relationship being quite diﬃcult to see. Similar plots are
13Figure 4: Scatterplots of innovation (t − 1) on growth (t − 1 : t). Top row: SIC 35; 2nd row:
SIC 36; 3rd row: SIC 37; bottom row: SIC 38. t=1985 on the left and t=1995 on the right.
14also obtained for the 3-digit sectors, although naturally we have fewer observations.
These scatterplots give us an opportunity to visualize the underlying nature of the data, to
‘have a look at the meat before we cook it’, so to speak, but it would be improper to base con-
clusions on them. In particular, such plots don’t take into account the need to control for any
potentially misleading inﬂuence on growth rates of lagged growth, size dependence (i.e. pos-
sible departures from Gibrat’s Law) and sectoral growth patterns. We therefore continue our
analysis with regression techniques.
4 Quantile Regression
We begin this section with a brief introduction to quantile regression, and then apply it to
our dataset.
4.1 An Introduction to Quantile Regression
Standard least squares regression techniques provide summary point estimates that calculate
the average eﬀect of the independent variables on the ‘average ﬁrm’. However, this focus on
the average ﬁrm may hide important features of the underlying relationship. As Mosteller
and Tukey explain in an oft-cited passage: “What the regression curve does is give a grand
summary for the averages of the distributions corresponding to the set of x’s. We could go
further and compute several regression curves corresponding to the various percentage points
of the distributions and thus get a more complete picture of the set. Ordinarily this is not
done, and so regression often gives a rather incomplete picture. Just as the mean gives an
incomplete picture of a single distribution, so the regression curve gives a correspondingly
incomplete picture for a set of distributions” (Mosteller and Tukey, 1977:266). Quantile re-
gression techniques can therefore help us obtain a more complete picture of the underlying
relationship between innovation and ﬁrm growth.
In our case, estimation of linear models by quantile regression may be preferable to the
usual regression methods for a number of reasons. First of all, we know that the standard
least-squares assumption of normally distributed errors does not hold for our database because
growth rates follow an exponential rather than a Gaussian distribution. The heavy-tailed
nature of the growth rates distribution is illustrated in Figure 5 (see also Stanley et al. (1996)
and Bottazzi and Secchi (2003) for the growth rates distribution of Compustat ﬁrms). It
appears that most ﬁrms experience very little growth in any given year, and what little they
do grow could be due to a wide range of idiosyncratic factors. We argue that investigating
the determinants of growth for such ﬁrms that hardly grow at all is of relatively little interest.




















Figure 5: The (annual) sales growth rates distribution for our four two-digit sectors. Sales
growth rates here are deﬂated to 1980 dollars using the CPI.
negligible fraction of ﬁrms experience a high growth rate, and it is precisely these fast-growth
ﬁrms that make a disproportionately large contribution to industrial development.
Whilst the optimal properties of standard regression estimators are not robust to modest
departures from normality, quantile regression results are characteristically robust to outliers
and heavy-tailed distributions. In fact, the quantile regression solution ˆ βθ is invariant to
outliers of the dependent variable that tend to ± ∞ (Buchinsky, 1994). Another advantage is
that, while conventional regressions focus on the mean, quantile regressions are able to describe
the entire conditional distribution of the dependent variable. In the context of this study, high
growth ﬁrms are of interest in their own right, we don’t want to dismiss them as outliers, but on
the contrary we believe it would be worthwhile to study them in some detail. This can be done
by calculating coeﬃcient estimates at various quantiles of the conditional distribution. Finally,
a quantile regression approach avoids the restrictive assumption that the error terms are
identically distributed at all points of the conditional distribution. Relaxing this assumption
allows us to acknowledge ﬁrm heterogeneity and consider the possibility that estimated slope
parameters vary at diﬀerent quantiles of the conditional growth rate distribution.
The quantile regression model, ﬁrst introduced in Koenker and Bassett’s (1978) seminal
contribution, can be written as:
yit = x
′
itβθ + uθit with Quantθ(yit|xit) = x
′
itβθ (1)
16where yit is the dependent variable, x is a vector of regressors, β is the vector of parameters
to be estimated, and u is a vector of residuals. Qθ(yit|xit) denotes the θth conditional quantile

























where ρθ(.), which is known as the ‘check function’, is deﬁned as:
ρθ(uθit) =
(
θuθit if uθit ≥ 0
(θ − 1)uθit if uθit < 0
)
(3)
Equation (2) is then solved by linear programming methods. As one increases θ con-
tinuously from 0 to 1, one traces the entire conditional distribution of y, conditional on x
(Buchinsky, 1998). More on quantile regression techniques can be found in the surveys by
Buchinsky (1998) and Koenker and Hallock (2001); for applications see Coad (2006) and also
the special issue of Empirical Economics (Vol. 26 (3), 2001). For a quantile regression analysis
of the relationship between innovation and market value (i.e. Tobin’s q), see Coad and Rao
(2006b).
4.2 Quantile regression results
We now estimate the following linear regression model:
GROWTHi,t = α+β1INNi,t−1 +β2GROWTHi,t−1 +β3SIZEi,t−1 +β4INDi,t +δt +ǫi,t (4)
where growth rates are calculated in the usual way by taking diﬀerences of logs of size (size
is measured by total sales). INNi,t−1 is the ‘innovativeness’ variable for ﬁrm i at time t − 1.
The control variables are lagged growth, lagged size and 3-digit industry dummies. We also
control for common macroeconomic shocks by including year dummies (δt).
Quantile regression results for the 2-digit sectors are presented in Figure 6. The OLS
estimates are presented as horizontal lines, together with their conﬁdence intervals. It is clear
that the OLS estimates do not tell the whole story. The quantile regression curves show that
the value of the estimated coeﬃcient on innovativeness varies over the conditional growth rate
distribution. When the quantile regression solution is evaluated at the median ﬁrm (i.e. at the
50% quantile), innovativeness only appears to have a small inﬂuence on ﬁrm growth. However,
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Figure 6: Variation in the coeﬃcient on ‘innovativeness’ (i.e. β1 in Equation (4)) over the
conditional quantiles. Horizontal lines represent OLS estimates with 95% conﬁdence intervals.
SIC 35: Machinery & Computer Equipment (top-left), SIC 36: Electric/Electronic Equipment
(top-right), SIC 37: Transportation Equipment (bottom-left), SIC 38: Measuring Instruments
(bottom-right). Graphs made using the ‘grqreg’ Stata module (Azevedo, 2004).
18The numerical results for OLS, ﬁxed-eﬀects and quantile regression estimation are reported
in Table 6. The coeﬃcients can be interpreted as the partial derivative of the conditional quan-
tile of y with respect to particular regressors, δQθ(yit|xit)/δx. Put diﬀerently, the derivative is
interpreted as the marginal change in y at the θth conditional quantile due to marginal change
in a particular regressor (Yasar et al., 2006). For each of the four sectors, the coeﬃcient on
innovativeness is much larger at the higher quantiles. At the 90% quantile, for example, the
coeﬃcient of innovativeness on growth is over 20 times larger than at the median, for two
of the four 2-digit sectors. The evidence here suggests therefore that, when we consider the
high-growth ﬁrms, investments in innovative activity make an important contribution to their
superior growth performance. (Note however that in some cases our results are not statistically
signiﬁcant.)
If they ‘win big’, innovative ﬁrms can grow rapidly. Conversely, there are many ﬁrms
that invest a lot in both R&D and patents that nonetheless perform poorly and experience
negative sales growth. Indeed, at the lowest quantiles, innovativeness is even observed to have
a negative eﬀect on ﬁrm growth. Admittedly, this result may appear counterintuitive at ﬁrst
but we can propose some tentative interpretations. First, it is quite likely that innovative
ﬁrms are more susceptible to spinoﬀs. (Remember that we are unable to identify spinoﬀs
in our dataset.) This would explain why, in some cases, increases in innovative activity are
associated with a subsequent decline in total sales. Second, it may be that innovation actually
does lead to a decline in sales in a minority of cases, because of the inherent uncertainty of
innovative activity. As Freel comments: “ﬁrms whose eﬀorts at innovation fail are more likely
to perform poorly than those that make no attempt to innovate. To restate, it may be more
appropriate to consider three innovation derived sub-classiﬁcations – i.e. ‘tried and succeeded’,
‘tried and failed’, and ‘not tried’” (Freel, 2000:208). Indeed, unless a ﬁrm strikes it lucky and
discovers a commercially viable innovation, its innovative eﬀorts will be no more than a waste
of resources.15
Similar results are obtained for the 3-digit industries, and these are shown in the lower
panel of Table 6 and in Figure 7. Once again, the OLS and ﬁxed-eﬀects estimators, which
focus on ‘the average eﬀect for the average ﬁrm’, are seen to do a poor job of summarizing the
relationship between innovativeness and growth. Quantile regression results indicate that, for
most ﬁrms, growth is only weakly related to innovativeness. However, fast-growth ﬁrms owe
a lot of their success to their innovative eﬀorts.
15In further exercises (not shown here) we tested this hypothesis by i) considering only those ﬁrms with
strictly positive patent intensities in each of the last three years (i.e. the ‘lucky ones’), and ii) considering only
those ﬁrms with above-median R&D intensities and yet no patents in the last three years (i.e. the ‘losers’).
In the case of i), we should expect that β1, the coeﬃcient on innovativeness, is more positive than for the
unrestricted sample, being positive even at the lower quantiles. In the case of ii), we should expect that the
coeﬃcient is more negative. It was encouraging to observe that the results did lean in the expected directions.
19Table 6: Quantile regression estimation of Equation (4): the coeﬃcient and t-statistic on ‘in-
novativeness’ reported for the 10%, 25%, 50%, 75% and 90% quantiles. Coeﬃcients signiﬁcant
at the 5% level appear in bold. Standard errors are obtained using 1000 bootstrap replications.
Quantile regression
OLS FE 10% 25% 50% 75% 90%
SIC 35 -0.0051 -0.0007 -0.0130 -0.0126 0.0029 0.0508 0.1338
(7298 obs.) -1.01 -0.10 -0.44 -1.44 0.16 1.28 2.77
[Pseudo-]R2 0.0575 0.0210 0.0690 0.0635 0.0638 0.0751 0.0952
SIC 36 0.0195 0.0219 -0.0237 0.0077 0.0290 0.0592 0.1145
(7469 obs.) 2.61 2.14 -2.00 0.61 2.10 4.61 3.15
[Pseudo-]R2 0.0665 0.0345 0.0452 0.0449 0.0574 0.0763 0.1001
SIC 37 0.0178 0.0274 -0.0295 -0.0009 0.0131 0.0263 0.0851
(2328 obs.) 2.36 2.73 -1.77 -0.09 1.62 2.57 3.69
[Pseudo-]R2 0.1000 0.082 0.0869 0.0826 0.0868 0.0804 0.0974
SIC 38 0.0147 0.0176 -0.0099 -0.0058 0.0114 0.0101 0.2652
(6511 obs.) 2.50 2.52 -0.11 -0.17 0.18 0.05 0.51
[Pseudo-]R2 0.0236 0.0058 0.0371 0.0320 0.0383 0.0491 0.0635
SIC 357 -0.0133 -0.0071 -0.0232 -0.0222 -0.0244 0.0174 0.0921
(2955 obs.) -2.17 -0.77 -0.26 -1.47 -1.18 0.35 1.03
[Pseudo-]R2 0.0562 0.0105 0.0781 0.0676 0.0673 0.0665 0.0659
SIC 367 0.0245 0.0457 -0.0323 -0.0086 0.0311 0.0549 0.0833
(2574 obs.) 2.49 3.91 -1.37 -0.51 2.45 4.21 2.75
[Pseudo-]R2 0.1079 0.0833 0.0805 0.0723 0.0799 0.1040 0.1483
SIC 384 0.0280 0.0377 -0.0618 -0.0122 -0.0177 0.1127 0.7407
(2492 obs.) 1.59 3.22 -0.50 -0.15 -0.17 0.36 1.21
[Pseudo-]R2 0.0265 0.0151 0.0496 0.0329 0.0319 0.0359 0.0655
SIC 283 0.0560 0.1040 -0.0332 -0.0138 0.0458 0.0889 0.4327
(2947 obs.) 5.54 4.81 -0.23 -0.60 2.78 1.16 2.71
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Figure 7: Variation in the coeﬃcient on ‘innovativeness’ (i.e. β1 in Equation (4)) over the
conditional quantiles. Horizontal lines represent OLS estimates with 95% conﬁdence intervals.
SIC 357: Computers and oﬃce equipment (top-left), SIC 367: Electronics (top-right); SIC
384: Medical Instruments (bottom-left) and SIC 283: Drugs (bottom-right).
215 Robustness Analysis
In the preceding analysis we have already provided some evidence suggesting that, for our
high-tech sectors, our results appear to be robust across sectors and also robust to sectoral
disaggregation. In this section we pursue our robustness analysis by repeating our analysis for
shorter subperiods (i.e. temporal disaggregation). We also check that our results are robust
when we take R&D or patents as measures of innovative activity instead of our composite
‘innovativeness’ index. Next, we show that our results are robust even when we use a diﬀerent
(but related) dataset – i.e. the Hall-Jaﬀe-Trajtenberg (2005) dataset. Finally, we present some
of our previously published results on the relationship between innovation and market value,
where market value can be seen as an alternative indicator of ﬁrm performance.
Temporal disaggregation To investigate the robustness of our results under temporal
disaggregation, we begin by splitting our sample into two subperiods – 1963-1983 and 1984-
1997. We have chosen to split our sample this way because, as shown in Figure 2 and 3,
there appears to be a structural break in the early 1980s after which the number of patents
in certain industries seems to increase. Furthermore, using statistical tests, Hall (2004) has
identiﬁed the year 1984 as corresponding to a signiﬁcant structural break for a number of
industries. The quantile regression results are reported in Table 7. Generally speaking, we
ﬁnd similar results when we repeat the analysis for the two sub-periods.
We also check the robustness of our results across shorter subperiods of ten years. Although
we have not reported these results here, we can conﬁrm that our results appear to be robust
when we consider speciﬁc decades.
R&D and patents as indicators of ‘innovativeness’ In the preceding analysis, we have
measured a ﬁrm’s innovative activity by constructing a synthetic ‘innovativeness’ variable
which was constructed from R&D and patent statistics. However, it may be argued that this
synthetic indicator is not very transparent, and that it would be preferable to analyse either
the patent statistics or the R&D statistics taken individually. In this section, therefore, we
take either a ﬁrm’s R&D stock or a ﬁrm’s patent stock as indicators of innovative activity.
The results are presented in Figures 8 and 9 and in Table 8.
Analysis of the Hall-Jaﬀe-Trajtenberg (2005) dataset It may be the case that the
reader is skeptical of our data construction methodology. As a result, we will now verify
the robustness of our results by repeating the analysis using the Hall-Jaﬀe-Trajtenberg (2005)
dataset that is available on Bronwyn Hall’s website.16. We repeat the analysis at the aggregate
16This database is publicly available (subject to conditions) from Bronwyn Hall’s website:
http://elsa.berkeley.edu/∼bhhall/bhdata.html
22Table 7: Exploring the robustness of our results under temporal disaggregation. Quantile re-
gression estimation of Equation (4): the coeﬃcient and t-statistic on ‘innovativeness’ reported
for the 10%, 25%, 50%, 75% and 90% quantiles. Coeﬃcients signiﬁcant at the 5% level appear
in bold. SE’s are obtained using 200 bootstrap replications.
Quantile regression
10% 25% 50% 75% 90%
1963-1983
SIC 35 0.0197 0.0190 0.1290 0.3089 0.3757
(2727 obs.) 0.16 0.41 1.59 3.19 4.04
[Pseudo-]R2 0.1133 0.1126 0.0973 0.0935 0.1122
SIC 36 -0.1124 0.0140 0.0501 0.0963 0.2283
(2654 obs.) -1.47 0.34 1.43 1.28 2.02
[Pseudo-]R2 0.0584 0.0780 0.0887 0.0897 0.0990
SIC 37 0.0009 -0.0038 0.0158 0.0199 0.0312
(1077 obs.) 0.03 -0.28 1.05 1.27 1.54
[Pseudo-]R2 0.1111 0.1070 0.0919 0.0757 0.0735
SIC 38 0.1664 0.2840 1.1739 1.4579 1.9366
(2001 obs.) 0.35 0.44 2.48 2.98 5.38
[Pseudo-]R2 0.0965 0.0768 0.0786 0.0834 0.0667
1984-1997
SIC 35 -0.0121 -0.0120 0.0030 0.0508 0.1299
(4571 obs.) -0.45 -1.47 0.16 1.30 3.32
[Pseudo-]R2 0.0528 0.0463 0.0513 0.0692 0.0862
SIC 36 -0.0243 0.0072 0.0222 0.0526 0.0945
(4815 obs.) -2.46 0.56 1.74 4.33 2.83
[Pseudo-]R2 0.0408 0.0320 0.0463 0.0740 0.1044
SIC 37 -0.0313 -0.0023 0.0110 0.0255 0.0823
(1251 obs.) -1.36 -0.15 1.10 1.90 3.18
[Pseudo-]R2 0.0671 0.0627 0.0883 0.0951 0.1256
SIC 38 -0.0052 -0.0048 0.0117 0.0105 0.2655
(4510 obs.) -0.06 -0.15 0.21 0.06 0.51
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Figure 8: Variation in the coeﬃcient on R&D intensity over the conditional quantiles. Conﬁ-
dence intervals (non-bootstrapped) extend to 2 standard errors in either direction. Horizontal
lines represent OLS estimates with 95% conﬁdence intervals. SIC 35: Machinery & Computer
Equipment (top-left), SIC 36: Electric/Electronic Equipment (top-right), SIC 37: Transporta-
tion Equipment (bottom-left), SIC 38: Measuring Instruments (bottom-right). Graphs made
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Figure 9: Variation in the coeﬃcient on patent intensity over the conditional quantiles. Conﬁ-
dence intervals (non-bootstrapped) extend to 2 standard errors in either direction. Horizontal
lines represent OLS estimates with 95% conﬁdence intervals. SIC 35: Machinery & Computer
Equipment (top-left), SIC 36: Electric/Electronic Equipment (top-right), SIC 37: Transporta-
tion Equipment (bottom-left), SIC 38: Measuring Instruments (bottom-right). Graphs made
using the ‘grqreg’ Stata module (Azevedo, 2004).
25Table 8: Exploring the robustness of our results using simpler indicators of innovative activity.
Quantile regression estimation of Equation (4): the coeﬃcient and t-statistic on ‘innovative-
ness’ reported for the 10%, 25%, 50%, 75% and 90% quantiles. Coeﬃcients signiﬁcant at the
5% level appear in bold. SE’s are obtained using 500 bootstrap replications.
Quantile regression
10% 25% 50% 75% 90%
3-year R&D stock
SIC 35 -0.0729 -0.0089 -0.0070 0.0310 0.0898
(7298 obs.) -1.81 -0.51 -0.57 1.08 1.34
[Pseudo-]R2 0.0708 0.0633 0.0638 0.0748 0.0922
SIC 36 -0.0580 -0.0145 0.0137 0.0774 0.1493
(7469 obs.) -2.63 -0.99 0.78 3.59 5.77
[Pseudo-]R2 0.0486 0.0449 0.0556 0.0749 0.1066
SIC 37 -0.3085 -0.1065 0.1835 0.4064 0.5721
(2328 obs.) -2.28 -0.78 2.00 2.33 4.58
[Pseudo-]R2 0.0936 0.0832 0.0879 0.0805 0.1088
SIC 38 -0.0005 -0.0001 -0.0002 -0.0002 0.0164
(6511 obs.) -0.27 -0.09 -0.07 -0.02 0.81
[Pseudo-]R2 0.0374 0.0322 0.0388 0.0476 0.0604
3-year patent stock
SIC 35 -0.0076 -0.0094 -0.0006 0.0036 0.0431
(7369 obs.) -0.93 -0.94 -0.03 0.12 1.51
[Pseudo-]R2 0.0670 0.0625 0.0631 0.0717 0.0816
SIC 36 -0.0147 0.0063 0.0244 0.0574 0.0863
(7535 obs.) -1.79 0.42 1.99 4.23 6.17
[Pseudo-]R2 0.0435 0.0447 0.0569 0.0692 0.0825
SIC 37 -0.0028 0.0235 0.0412 0.0465 0.0742
(2407 obs.) -0.08 0.76 1.61 1.26 1.67
[Pseudo-]R2 0.0829 0.0850 0.0865 0.0698 0.0667
SIC 38 -0.0003 0.0006 0.0005 0.0033 0.0130
(6535 obs.) -0.04 0.17 0.10 0.27 0.56
[Pseudo-]R2 0.0365 0.0319 0.0390 0.0500 0.0615
26Table 9: Exploring the relationship between innovation and sales growth using the Hall-Jaﬀe-
Trajtenberg (2005) dataset. Quantile regression estimation of Equation (4): the coeﬃcient
and t-statistic on ‘innovativeness’ reported for the 10%, 25%, 50%, 75% and 90% quantiles.
To make the results more readable, the regression coeﬃcients are scaled up by a factor of 1000.
Coeﬃcients signiﬁcant at the 5% level appear in bold. SE’s are obtained using 1000 bootstrap
replications.
Quantile regression
10% 25% 50% 75% 90%
R&D stock (deﬂated, depreciated and scaled by (lagged) sales)
coeﬀ 0.0308 0.0260 0.0351 0.0811 0.1283
(8053 obs.) 1.50 2.21 2.79 3.72 3.36
[Pseudo-]R2 0.0546 0.0486 0.0471 0.0610 0.0840
Patent stock (depreciated and scaled by (lagged) sales)
coeﬀ 0.1747 0.0823 0.0795 0.1311 0.2381
(8053 obs.) 2.13 1.87 2.32 2.46 2.16
[Pseudo-]R2 0.0547 0.0486 0.0486 0.0599 0.0816
level, measuring innovative activity in terms of R&D expenditure or patent counts.17
The quantile regression results are reported in Table 9. The results show that the coeﬃcient
on innovative activity (proxied by either R&D or patent intensities) is much higher for the
fastest growing ﬁrms (i.e. those ﬁrms at the upper conditional growth rate quantile). However,
we observe that the results using the patent intensity are less impressive than those obtained
from using the R&D statistics. This is in line with the discussion in Hall et al. (2005), who
present evidence that R&D expenditure is a preferable indicator of innovative activity than
raw patent counts.
Innovation and market value In the Introduction we observed that it might take a long
time for a successful innovation to materialize as an increase in sales. Proﬁts might therefore
be a preferable indicator of ﬁrm performance. As a result, it might be of interest to consider
the relationship between innovation and market value, where a ﬁrm’s market value is taken
to reﬂect a ﬁrm’s future proﬁt stream. Furthermore, whilst Scherer (1965) observed that
successful innovation was translated into an increase in sales with roughly constant proﬁt rates,
Geroski and Machin (1992) observed that innovation had a larger eﬀect on proﬁt margins than
on total sales. As a result, it is worthwhile to continue our analysis with an investigation the
relationship between innovative activity and market value. This analysis was performed using
17In the ‘hjtgood.dta’ dataset, some of the ﬁrm-speciﬁc identiﬁers contain non-numerical characters (i.e. let-
ters). We remove these observations using the following Stata command – ‘destring cusip, generate(ﬁrm)
force’. This makes us lose 116 observations (which corresponds to under 1% of the sample). Our measure for
patent stock is the variable ‘pstock’ and our measure for R&D stock is ‘kdef92’ – both of these are scaled down
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Figure 10: Variation in the importance of innovative activity on market value over the con-
ditional quantiles of the market value distribution. Conﬁdence intervals extend to 95% conﬁ-
dence intervals in either direction (for computational manageability, we use the Stata default
setting of 20 replications for the bootstrapped standard errors). Horizontal lines represent
OLS estimates with 95% conﬁdence intervals. SIC 35: Machinery & Computer Equipment
(top left), SIC 36: Electric/Electronic Equipment (top right), SIC 37: Transportation Equip-
ment (bottom left), SIC 38: Measuring Instruments (bottom right). Graphs made using the
‘grqreg’ Stata module (Azevedo 2004). Source: Coad and Rao (2006b).
a similar database and the methodology is described in detail in Coad and Rao (2006b).
The results are presented in Figure 10. We observe a similar pattern emerging as for the
case of innovation and sales growth. For the median ﬁrm, innovation has a relatively modest
inﬂuence on a ﬁrm’s market value. For the ﬁrms with the highest market value, however,
innovative activity is seen to have a much more important eﬀect.
6 Conclusions and Implications for Policy
In modern economic thinking, innovation is ascribed a central role in the evolution of indus-
tries. In a turbulent environment characterized by powerful forces of ‘creative destruction’,
ﬁrms can nonetheless increase their chances of success by being more innovative than their
competitors. Investing in R&D is a risky activity, however, and even if an important discovery
is made it may be diﬃcult to appropriate the returns. Firms must then combine the inven-
28tion with manufacturing and marketing know-how in order to convert the basic ‘idea’ into a
successful product - only then will innovation lead to superior performance. The processes of
creating competitive advantage from ﬁrm-level innovation strategies are thus rather complex
and were the focus of this paper.
Nevertheless, and perhaps surprisingly, the bold conjectures on the important role of in-
novation have largely gone unquestioned. This is no doubt due to diﬃculties in actually
measuring innovation. Whilst variables such as patent counts or R&D expenditures do shed
light on the phenomenon of ﬁrm-level innovation, they also contain a lot of irrelevant, idiosyn-
cratic variance. In this study, innovation was measured by using Principal Component analysis
to create a synthetic ‘innovativeness’ variable for each ﬁrm in each year. This allows us to
use information on both R&D expenditure and patent statistics to extract information on the
unobserved variable of interest, i.e. ‘increases in commercially useful knowledge’, whilst dis-
carding the idiosyncratic variance of each variable taken individually. We observe that a ﬁrm,
on average, experiences only modest growth and may grow for a number of reasons that may
or may not be related to ‘innovativeness’. However, while standard regression analyses focus
on the growth of the mean ﬁrm, such techniques may be inappropriate given that growth rate
distributions are highly skewed and that high-growth ﬁrms should not be treated as outliers
but instead are objects of particular interest. Quantile regressions allows us to parsimoniously
describe the importance of innovativeness over the entire conditional growth rate distribution,
and we observed that, compared to the average ﬁrm, innovation is of great importance for the
fastest-growing ﬁrms.
In the sectors studied here, there is a great deal of technological opportunity. Competi-
tion in such sectors is organized according to the principle that a successful (and fortunate)
innovator may suddenly come up with a winning innovation and rapidly gain market share.
The reverse side of the coin, of course, is that a ﬁrm that invests in R&D but does not make a
discovery (either through missed opportunities or just plain bad luck) may rapidly forfeit its
market share to its rivals. As a result, ﬁrms in turbulent, highly innovative sectors can never
be certain how they will perform in future. Innovative ﬁrms may either succeed spectacularly
or (if they don’t happen to discover a commercially valuable innovation) they may waste a
large amount of resources, whilst their market share is threatened by more successful rivals.
This may be because they have inferior R&D capabilities or it may just be because they were
unlucky. Innovative activity is highly uncertain and although it may increase the probability
of superior performance, it cannot guarantee it. We are thus wary of innovation policies of
narrow scope that put ‘all the money on one horse’ and focus on just one or a few ﬁrms.
Instead, our results favour broad-based innovation policies that oﬀer support to many ﬁrms
engaged in multiple directions of search, because it may not be possible to pick out ex ante
the winners from the losers.
29We have seen that, on average, ﬁrms have a lot of discretion in their growth rates. Inno-
vation is uncertain and generally lacks persistence (Geroski, 2000; Ceﬁs and Orsenigo, 2001);
similarly, ﬁrm growth is highly idiosyncratic and lacks persistence – inspite of this circumstan-
tial evidence, however, we should resist the temptation to overplay the relationship between
innovativeness and ﬁrm growth. On the whole, ﬁrm growth is perhaps best modelled as a
random walk (Geroski, 2000). Only a small group of highly-innovative ﬁrms are identiﬁed
and rewarded by selection pressures. Although the virtues of selective pressures operating
on heterogeneous ﬁrms have been extolled in theoretical contributions (e.g. Alchian, 1950),
it appears here that selection only wields inﬂuence over the outliers (this is in line with a
conjecture in Bottazzi et al. (2002)). Most ﬁrms, it seems, are quite oblivious to selection.
We should thus avoid the Panglossian view that unseen market forces reward the ﬁttest and
eliminate the weakest to take the economic system to an ‘optimum’. The evidence presented
here suggests that selection is not particularly eﬃcient (see also Coad, 2005). However, can
selection be stimulated or reinforced by intervention? This is a policy question we leave open.
We simply note here that if the ‘viability’ of ﬁrms is open to manipulation or observed with
error, the results of such intervention could be counterproductive.
Many years ago, Keynes wrote: “If human nature felt no temptation to take a chance, no
satisfaction (proﬁt apart) in constructing a factory, a railway, a mine or a farm, there might not
be much investment merely as a result of cold calculation” (1936:150) - the same is certainly
true for R&D. Need it be reminded, an innovation strategy is even more uncertain than playing
a lottery, because it is a ‘game of chance’ in which neither the probability of winning nor the
prize can be known for sure in advance. In the face of such radical uncertainty, some ﬁrms may
well be overoptimistic (or indeed risk-averse) about what they will actually gain. For other
ﬁrms, there may be over-investment in R&D because of the ‘managerial prestige’ attached
to having an over-sized R&D department.18 As a result, we cannot rule out the possibility
that many ﬁrms invest in R&D far from something which could correspond to the ‘proﬁt-
maximizing’ level (whatever ‘proﬁt-maximizing’ may mean). In fact, we remain pessimistic
that R&D will ever enter into the domain of ‘rational’ decision-making (i.e. a ‘cost-beneﬁt
analysis’). Successful innovation, and the ‘super-star’ growth performance that may result,
require risk-taking and perhaps just a little bit of craziness.
18In analogy to the principles of managerial economics, we advance that if the size of the R&D lab enters
into the R&D manager’s utility function, then investment in R&D may be far above the ‘proﬁt-maximizing’
level. Consider here the examples of the prestigious Bell Laboratories or Xerox’s renowned Palo Alto Research
Centre, which came up with many great inventions and generated several Nobel prizes, but were unable to
make any money from these ideas (Roberts, 2004).
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